Rx-360, a global nonprofit pharmaceutical supply chain consortium, announced on Tuesday that it has partnered with Leucine, an AI-powered pharmaceutical manufacturing and compliance platform.

Through this collaboration, Rx-360 consortium members will receive complimentary access to Leucine's FDA Tracker Premium, an advanced regulatory intelligence platform designed to help pharmaceutical manufacturers proactively monitor FDA activity, assess risk, and stay continuously inspection-ready.

FDA Tracker Premium delivers real-time intelligence across FDA inspections, Form 483s, and warning letters -- providing deep analytics on investigators, subsystems, and enforcement trends.

The platform helps quality and compliance leaders predict potential risks, benchmark performance against industry peers, and prepare more effectively for upcoming inspections, Rx-360 said.